Previous close | 76.50 |
Open | 76.00 |
Bid | 67.30 |
Ask | 70.70 |
Strike | 290.00 |
Expiry date | 2024-09-20 |
Day's range | 75.20 - 76.50 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Business Roundtable and The Cigna Group brought together senior business executives, federal policymakers and community leaders last night for a Workforce Mental Health Summit in the nation's capital. The event was part of the Business Roundtable Mental Health Initiative, a CEO-led effort to help companies promote and support employee mental health, championed by David M. Cordani, Chairman and CEO of The Cigna Group (NYSE:CI). During the event, leaders in business and government provided perspec
In a lawsuit filed in federal court in Missouri, Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), demanded that the Federal Trade Commission ("FTC" or the "Commission") retract its July 2024 report, which is filled with false and misleading claims about the pharmacy benefit management (PBM) industry and fails to serve the interests of American consumers.
CI's new launch, a new E-Treatment option, is expected to improve patient satisfaction and operational efficiency.